AI assistant
Sending…
Oncopeptides — Major Shareholding Notification 2021
Mar 11, 2021
3091_iss_2021-03-11_3fecc5df-87a2-4871-8f7c-b0811d634765.pdf
Major Shareholding Notification
Open in viewerOpens in your device viewer

Issuer Oncopeptides AB
Holder
Stiftelsen Industrifonden
Instrument
| Instrument | Ordinary shares |
|---|---|
| Before the transaction | |
| Shares | 0 |
| Voting rights | 0 |
| Transaction | |
| Reason for major shareholding notification Share loan | |
| Date | 10/03/2021 |
| Limit for number of shares | 10 % |
| Limit for number of votes | 10 % |
| After the transaction | |
| Quantity | |
| Shares | 3,920,805 |
| Directly held voting rights | 3,920,805 |
| Indirectly held voting rights | 0 |
| Percentage | |
| Directly held shares | 5.7587 % |
| Directly held voting rights | 5.7587 % |
| Indirectly held voting rights | 0 % |
Resulting distribution of total holdings
| Percentage of voting rights: |
Number of underlying shares: |
|
|---|---|---|
| Shares | 5.7587 % | 3,920,805 |
| Instruments - FITA Ch. 4, section 2, first paragraph, line 2 Instruments - FITA Ch. 4, section 2, first paragraph, line 3 |
5.14065 % | 3,500,000 |
| - Physically settled - Cash settled |
||
| Total | 10.89935 % | 7,420,805 |
Group total holdings
Voting rights 3,920,805 Percentage of voting rights 5.7587
Notes (other relevant informations according to law)
Flaggningen avser utlån av aktier i samband med nyemission i Oncopeptides. Flaggningen är baserad på 68 084 855 utestående aktier i Oncopeptides per 10 mars 2021, dagen då flaggningsskyldigheten uppstod.
Published
11/03/2021 14:02
Contact
Name Jonas Brambeck
Phone +46 70 879 19 37 Email [email protected]
CLOSE PRINT
[email protected] Tfn 08-408 980 37 Fax 08-24 39 25
More from Oncopeptides
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Declaration of Voting Results & Voting Rights Announcements
2026
May 21
Interim / Quarterly Report
2026
May 13
Interim / Quarterly Report
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 11
Annual Report
2026
Apr 28
Major Shareholding Notification
2026
Apr 24
Major Shareholding Notification
2026
Apr 21
Proxy Solicitation & Information Statement
2026
Apr 16